Insights On Solid Dose Manufacturing

  1. Advancements In GLP-1 Analog Formulation: Overcoming Challenges 2/3/2025

    Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.

  2. Manufacturing For Oral Solid Dose Success 6/30/2025

    Adare Pharma Solutions provides end-to-end CDMO services for oral solid dose drugs, enabling efficient development, manufacturing, and packaging with advanced technologies and global scale.

  3. Innovative ASD Technology Improves Abandoned Cancer Medication 3/1/2024

    Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.

  4. Softgel Formulation: Addressing Stability, Shelf-Life, And Bioavailability 5/16/2024

    A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.

  5. Seizing Market Share Pre-Patent Expiry: The Evolution Of A CDMO Partnership In Navigating A Paragraph IV ANDA Submission 6/26/2024

    The dynamic pharmaceutical landscape demands agility and strategic foresight. Explore how leveraging a key partnership helped to overcome a looming patent expiry for a second-generation acne medication.

  6. A Solvent-Free, Fusion-Based ASD Manufacturing Process 3/5/2024

    Explore a solvent-free alternative for the production of amorphous solid dispersions (ASDs) that not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.

  7. Less Mess, Less Stress, Best Expressed: An Alternative To Spray Drying 7/16/2024

    Although well-established processes, spray drying and hot-melt extrusion can be outperformed in bioavailability, cost-savings, manufacturing speed, environmental impact, and more.

  8. The Art And Science Of Pre-Picking Tablet Designs 7/30/2024

    Picking and sticking are the most common tablet defects that can reduce your product quality and performance. This makes perfecting the right pre-picking strategy essential to improving your processes.

  9. Advancing Patient-Centric Drug Delivery For Neurodegenerative Disease With Orally Dissolving Tablets 1/27/2025

    Pharmaceutical companies must prioritize patient-centric dosage forms to address challenges like dysphagia, enhance medication compliance, and improve therapeutic outcomes.